Detalles de la búsqueda
1.
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors).
Rev Soc Bras Med Trop
; 56: e0565, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37075454
2.
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)
Rev. Soc. Bras. Med. Trop
; 56: e0565, 2023. tab, graf
Artículo
en Inglés
|
LILACS-Express
| ID: biblio-1431408
Resultados
1 -
2
de 2
1
Próxima >
>>